Clene Nanomedicine   Report issue

For profit Phase 2 Phase 3
Founded: Salt Lake City UT United States (2012)

Organization Overview

First Clinical Trial
2018
NCT03536559
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Clene Australia Pty Ltd | Clene Nanomedicine